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1. Introduction 
The Correa model of gastric cancer reported that atrophy (parietal cell loss) was one of 
several significant changes that occurred after chronic inflammation (Correa et al., 1975). We 
now understand that the major cause of chronic inflammation in the normal, acid-secreting 
stomach is Helicobacter pylori (H. pylori) bacterial colonization. It is widely accepted that 
inflammation that is caused by H. pylori infection is a trigger for the development of gastric 
cancer. An explanation for the causal role of H. pylori infection in the pathogenesis of gastric 
cancer has been described by disruption of differentiation of epithelia as a consequence of 
elevated pro-inflammatory cytokines such as IFNγ, TNFα and IL-1β (Moss et al., 1994; Padol 
IT, 2004; Sawai et al., 1999; Smythies et al., 2000; Zavros et al., 2003). However, the question 
of the mechanism by which inflammatory cytokines induce mucosal damage remains 
unanswered. Since stomach secretes numerous factors such as TGFβ, Wnt, FGFs and 
Hedgehog proteins that are known to be responsible for the differentiation of the gastric 
epithelium, one favored explanation linking inflammation and progression to cancer is due 
to the loss of these factors (reviewed in (Katoh Y, 2006)). During the progression from 
inflammation to metaplasia and cancer the cell composition of the stomach changes. In 
particular, loss of the acid-secreting parietal cells (atrophy) leads to alterations in the cell 
lineages with the expansion of metaplastic mucous cells. 
Emerging evidence shows that Sonic Hedgehog (Shh) signaling is expressed in acid-
secreting parietal cells within the adult stomach (van den Brink et al., 2002; Zavros et al., 
2008). Since studies have suggested that Shh acts as a morphogen in the adult stomach 
(Shiotani et al., 2005a; van den Brink et al., 2002), an important hypothesis is that loss of Shh 
expression during gastric inflammation results in the disruption of epithelial cell 
differentiation and function leading to cancer. During H. pylori infection, the site of chronic 
inflammation coincides with the secretion of IFNγ and the engraftment of bone marrow-
derived mesenchymal stem cells (BM-MSCs) whose progeny populate gastric tumors 
(Houghton et al., 2004). The mechanism that regulates BM-MSC proliferation and cellular 
engraftment with host cells during chronic inflammation is unknown. 
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The permanent engraftment of the BM-MSCs in an area of an IFNγ-rich and abnormal tissue 
environment results in differentiation of these cells through stages of metaplasia and 
dysplasia (Li et al., 2006). For this reason these cells behave much like cancer stem cells 
whereby they have acquired the ability to self-renew and become incorporated into the 
developing tumor (Li et al., 2006). The mechanism that regulates BM-MSC proliferation and 
cellular engraftment with host cells during chronic inflammation is unknown, but based on 
our studies these cells secrete Shh that is responsible for the proliferation and thus may 
contribute to the differentiation into tumors. In pathological conditions in which immune 
cells have been implicated, the Hedgehog signaling pathway mediates IFNγ-induced tumor 
development (Stewart et al., 2003; Wang et al., 2003; Zavros et al., 2005). Given that chronic 
gastritis is associated with elevated IFNγ expression and the development of cancer (Zavros 
et al., 2005) a similar mechanism may be occurring in the stomach. The current chapter focuses 
on the Shh signaling pathway and its role in the development of gastric cancer, specifically in 
response to Helicobacter pylori infection. In particular, the chapter presents a comprehensive 
discussion of the role of the Hedgehog signaling network as a regulatory mechanism within the BM-
MSC compartment during the development of gastric cancer. 
2. Role of Shh as a regulator of gastric tissue homeostasis and disease 
2.1 Discovery, processing and signaling 
Using a saturation mutagenesis screen performed to study the effect of mutations on the 
patterning of segmented Drosophila embryos, Nüsslein-Volhard and Wieschaus first 
discovered Hedgehog (Nüsslein-Volhard & Wieschaus, 1980). As a result of the mutagenesis 
screen, Nüsslein-Volhard & Wieschaus identified a group of Drosophila mutants that 
remained covered entirely with denticles (Nüsslein-Volhard & Wieschaus, 1980). The 
inspiration for the name Hedgehog came from the “spiny” phenotype of the embryos, 
which resembled a hedgehog. Since the identification of the Hedgehog mutant, three 
vertebrate Hedgehog homologs have been identified that include Sonic hedgehog (Shh), 
Indian hedgehog (Ihh), and Desert hedgehog (Dhh). Of the Hedgehog homologs, Shh has 
been the most studied in terms of the Hedgehog signaling pathway in vertebrates and in 
particular gastric function and disease. 
In Drosophila or zebrafish models (Porter et al., 1995), Shh is synthesized as a 45-kDa 
precursor protein. The full-length protein subsequently undergoes an autocatalytic cleavage 
to yield a 26-kDa carboxy-terminal fragment and a 19-kDa amino-terminal fragment (ShhN). 
ShhC is responsible for catalyzing cleavage of the 45-kDa precursor protein while ShhN is 
the active signaling fragment. Concomitant with cleavage, ShhC acts as a cholesterol 
transferase covalently linking a cholesterol moiety to the carboxy-terminus of the 19-kDa 
fragment (ShhN) (Goetz et al., 2006). The 19-kDa fragment (ShhN) is further modified by a 
membrane bound O-acyltransferase commonly known as Skinny hedgehog (Ski), which 
covalently links a molecule of palmitate to the 19- kDa fragment (ShhNp) (Mann et al., 2004; 
Torroja et al., 2005). The phenotypes of Drosophila lacking Ski resemble those of Drosophila 
with Shh knocked out and thus demonstrating the importance of palmitoylation for Shh 
signaling (Chamoun et al., 2001; Pepinsky et al., 1998). ShhNp can remain anchored to the 
cell membrane or form secreted, soluble and freely diffusible multimeric units (Goetz et al., 
2006). Both the cell-retained and secreted Shh protein fragments are able to activate 
hedgehog signaling through the hedgehog receptor Ptch (Goetz et al., 2006) (Figure 1A). 
However, recently it is reported that the full-length precursor Shh protein may also bind to 
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Ptch and exhibits biological activity (Tokhunts et al., 2009). In an in vivo assay using the 
developing chick neural tube, full-length Shh induced activation of Shh-dependent luciferase 
reporter gene (Tokhunts et al., 2009). Such findings are relevant when considering the 
biological activity of Shh with regards to gastric cancer. Prior studies using xenografts of 
human gastric cancer cell lines show that Hedgehog signaling is required for cancer cell 
growth. It has been assumed that the Shh ligand mediating the activation was the processed 
ShhN protein, but the form of Shh produced by the xenografts was not evaluated directly in 
these studies (Berman et al., 2003). In another study using human gastric tumor samples it 
was observed that the major form of the Shh ligand present is the 45-kDa peptide (Zavros et 
al., 2007). However, it remains to be determined whether full-length Shh has any biologic 
activity and acts as a regulator of tumorigenesis that differs from the processed 19-kDa form. 
 
 
Fig. 1. Schematic diagram of Shh processing and signaling. (A) The cleavage of the 45-kDa 
full-length precursor generates the signal peptide (39kDa). Autocatalytic or protease-
dependent cleavage yields a secreted 19-kDa fragment and a 26-KDa cholesterol modified 
cell bound protein (ShhNp). (B) In the absence of Shh ligand or unstimulated cells, the 
activity of the transmembrane protein Smo is suppressed by the Hedgehog receptor Ptch. 
(C) Binding of Shh to Ptch results in the removal of the inhibitory restraint of Ptch on Smo, 
consequently activating Smo. Smo then transduces the Shh signal into the cytoplasm. 
Transduction of the Shh signal into the cytoplasm leads to activation of the Glioblastoma 
(Gli) family of transcription factors and activation of downstream targets 
www.intechopen.com
 Cancer Stem Cells - The Cutting Edge 
 
316 
Shh processing within the gastric mucosa appears to have diverged from the autocatalytic 
processing originally reported in Drosophila and zebrafish models (Porter et al., 1995; Zavros 
et al., 2007; Zavros et al., 2008). In the mammalian stomach, Shh processing is hormonally 
regulated and acid dependent (Zavros et al., 2007; Zavros et al., 2008). Changes in acid 
secretion, that is stimulated by both histamine and gastrin, induces Shh expression and 
processing (Zavros et al., 2007; Zavros et al., 2008). In particular, intracellular calcium release 
and protein kinase C activation stimulate Shh gene expression during gastric acid secretion 
(El-Zaatari et al., 2010). Subsequently, within the acidic environment pepsin A cleaves the 
45-kDa precursor protein into the biologically active 19-kDa protein (Zavros et al., 2007). 
These studies indicate that although autocatalytic processing of Shh may occur in the gastric 
mucosa, processing of the 45-kDa Shh precursor may predominantly require acidic 
conditions and the acid-activated protease pepsin A. 
Shh signaling in vertebrates is mediated by the seven-span transmembrane receptor 
Smoothened (Smo) (Goodrich et al., 1996; Taipale et al., 2002). Shh indirectly controls the 
activity of Smo through binding to the Patched (Ptch) receptor (Goodrich et al., 1996; Taipale 
et al., 2002). Ptch is a twelve-span transmembrane receptor that catalytically inhibits 
signaling through Smo in the absence of Hedgehog (Goodrich et al., 1996; Taipale et al., 
2002) (Figure 1B). Binding of Hedgehog to Ptch relieves the inhibitory effect of Ptch on Smo 
and consequently activates Smo (Goodrich et al., 1996; Taipale et al., 2002) (Figure 1C). 
Transduction of the Hedgehog signal into the cytoplasm leads to activation of the 
Glioblastoma (Gli) family of transcription factors and target genes that are known to 
regulate cell cycle, proliferation and differentiation (Hui CC, 1994). 
2.2 The role of Shh as a regulator of gastric tissue homeostasis 
Evidence for the crucial role of Shh as a regulator of gastrointestinal development comes 
from the Shh null mouse models (Shh-/- mice), whereby Shh-/- mouse stomachs exhibit an 
intestinal rather than gastric-type mucosa (Kim et al., 2005; Ramalho-Santos et al., 2000). It is 
only recently that the direct role of Shh in the adult stomach has been investigated 
(Waghray et al., 2010; Xiao et al., 2010; Zavros et al., 2008). Shh is believed to regulate 
epithelial cell differentiation, but its role as a morphogen is based on evidence that correlates 
the loss of Shh with inflammation of the adult stomach (Shiotani et al., 2005a; Suzuki et al., 
2005; van den Brink et al., 2002). In the absence of inflammation, the direct contribution of 
reduced Shh expression to the disruption of epithelial cell differentiation and cancer 
progression had never been tested. We have made significant contributions that have 
advanced the current understanding of not only the role of Hedgehog in the adult stomach, 
but also the mechanism regulating Shh secretion (Xiao et al., 2010; Zavros et al., 2008). Our 
laboratory is responsible for discovering that in the mammalian system, Shh secretion from 
parietal cells is acid- and hormonally-regulated (Zavros, 2007; Zavros et al., 2008). Moreover, 
we show that Shh from this acid-secreting single cell type has significant biological activity, 
regulating the differentiation of cell lineages and controlling gastric physiological function 
(Xiao et al., 2010). 
The development of a mouse model expressing a parietal cell-specific deletion of Shh 
(HKCre/ShhKO mice) has allowed us to assay changes in gastric epithelial cell differentiation 
and function in the adult stomach (Xiao et al., 2010). The HKCre/ShhKO mouse 
demonstrated an age-dependent increase in the number of surface pit mucous cells. The 
surface mucous cell expansion that was observed in the HKCre/ShhKO mice was 
reminiscent of foveolar hyperplasia observed in the over-expressing TGFα transgenic mice 
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(Bockman et al., 1995; Goldenring et al., 1996; Nomura S, 2005) and in patients with 
Menetrier’s disease (Larsen et al., 1987; Wolfsen et al., 1993). However, unlike Menetrier’s 
disease and H. pylori infected patients, the HKCre/ShhKO mouse model did not develop loss 
of parietal cells (atrophy). Given that HKCre/ShhKO mice lacked inflammation, this suggests 
a requirement for additional factors, such as inflammatory cytokines, for parietal cell 
atrophy to occur. The overproduction of surface mucous cells often occurs at the expense of 
other cell lineages such as the zymogen cells (Bockman et al., 1995; Goldenring et al., 1996). 
Consistent with this notion, we observed that the HKCre/ShhKO mice also had delayed 
differentiation of the zymogen cell lineage from the mucous neck cells in the stomachs of 
HKCre/ShhKO mice (Xiao et al., 2010). Although we have acquired new knowledge of 
Hedgehog signaling and gastric differentiation and function, the HKCre/ShhKO mice have 
experimental limitations. 
The HKCre/ShhKO mouse is a constitutive model of parietal cell-expressed Shh. Thus, Shh is 
deleted during development when the H+,K+-ATPase is expressed and is not re-expressed in 
the gastric parietal cell. In mice, this means Shh would be deleted on embryonic day 19 
when H+,K+-ATPase has developed and is expressed within parietal cells (Pettitt et al., 
1992). We have created a complimentary experimental approach by developing an advanced 
mouse model expressing a tamoxifen-inducible parietal cell-specific deletion of Shh 
(HKCreERT2/ShhKO). There are two major advantages to using the inducible 
HKCreERT2/ShhKO mice for the proposed studies and these include: 1) the inducible model 
will give us the ability to identify the role of Shh signaling in the adult stomach in a fully 
differentiated epithelium, and 2) the inducible HKCreERT2/ShhKO mice is an approach that 
will allow us to assay changes in epithelial cell differentiation and function in relation to the 
loss and gain of Shh expression, independent of inflammation. Clinically this is important 
given that re-expression of Shh in H. pylori-infected patients after eradication of bacterial 
infection results in regeneration of the gastric epithelium and ulcer healing (Kang et al., 
2009; Shiotani et al., 2005a; Suzuki et al., 2005). 
Observations made in the HKCre/ShhKO mice have allowed us to formulate hypotheses 
explaining the role of Hedgehog signaling in the stomach. The HKCre/ShhKO mice lacked 
the ability to secrete acid in response to histamine that was accompanied by severe 
hypergastrinemia and decreased somatostatin expression (Xiao et al., 2010). 
Hypergastrinemia was associated with increased Indian Hedgehog (Ihh) consistent with 
observations made in human stomach where Ihh was predominantly expressed in the pit 
cells where it induces pit cell differentiation in primary mouse gastric cells (Fukaya et al., 
2006). Thus, the phenotype observed with loss of Shh may be attributed to increases in 
circulating gastrin concentrations due to loss of somatostatin. Besides the proposed role as a 
morphogen for the gastric epithelium, Shh may also be a fundamental regulator of the 
gastrin-gastric acid negative feedback mechanism. 
Loss of Shh is accompanied by increased Ihh gene expression in the surface pit epithelium 
(Xiao et al., 2010). As shown in Figure 1, binding of Hedgehog ligand to its receptor Ptch 
results in removal of the inhibition of Ptch on Smo, and this removal of the inhibition on 
Smo subsequently results in the activation of the Gli-family of Hedgehog transcription 
factors. Evidence from Gli1 pathway studies in rat kidney epithelial cells (RK3E) show that 
Gli1 induces the transcription of the zinc-finger transcription factor, Snail (Li et al., 2006). 
Snail inhibits transcription of E-cadherin, an integral cell-adhesion protein known to 
associate with β-catenin at the cell membrane. Suppression of E-cadherin expression is 
implicated with increased nuclear β-catenin and activation of Wnt pathway targets such as 
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CD44, MMP-7, c-Myc and Cyclin D1 that have been associated with the progression of 
gastric cancer (Tanaka M, 2002). In vitro data shows that the Hedgehog signaling pathway is 
a key regulator of β-catenin (Li et al., 2007), but whether Shh maintains the differentiated 
phenotype of the stomach by mediating Wnt pathway activation is unknown. Collectively, 
loss of Shh triggers a number of molecular events, including increased Snail and loss of E 
cadherin expression, translocation of β catenin and activation of the Wnt pathway, that are 
consistent with epithelial-to-mesenchymal transition (EMT) of gastric epithelial cells (Li et 
al., 2006). 
Evidence from the HKCre/ShhKO mice demonstrated that loss of Shh triggers epithelial 
changes consistent with EMT, that included increased Snail accompanied by loss of E 
cadherin expression (Xiao et al., 2010). While bringing to light that loss of Shh in the 
stomach contributes to the development of EMT, we turned our attention to tight junctions 
as a marker of epithelial integrity. In the stomach, the expression pattern of tight-junction 
scaffolding protein ZO-1 determines epithelial cell organization, differentiation and 
function, in particular the zymogen cell lineage (Zhu et al., 2009). Disruption of the tight-
junction complex is characteristic of a number of diseases including H. pylori gastritis 
(Amieva et al., 2003; Krueger S, 2007). Evidence collected from studies using primary mouse 
epithelial cell cultures over-expressing Snail demonstrates that Snail directly represses gene 
expression of claudins/occludin (Ikenouchi et al., 2003). Snail also causes translocation of 
ZO-1 from the membrane to the cytoplasm in the same isolated mouse epithelial cell 
cultures (Ikenouchi et al., 2003). In addition, the HKCre/ShhKO mice develop severe 
hypergastrinemia (Xiao et al., 2010). Besides the contribution of Snail to the disruption of 
tight-junctions in the stomach, the hypergastrinemia induced in the HKCre/ShhKO mice 
may also explain the disrupted ZO-1 expression. In support of this notion, progastrin causes 
the dissociation of tight-junctions by delocalizing ZO-1 and occludin from the membrane to 
the cytoplasm in IMGE-5 cells (Hollande et al., 2003). Collectively, these studies support that 
deletion EMT of the gastric epithelium contributes to the dissociation of tight-junction 
protein ZO-1 and warrants further investigation. 
Aside from its role as a regulator of gastric epithelial cell differentiation, Shh may also act to 
regulate the physiological secretion of acid from the parietal cells. In response to EGF, 
parietal cells express Shh which positively regulates the expression of the H+,K+-ATPase 
(Stepan et al., 2005). Emerging studies using mouse models in which Shh signaling or 
expression have been pharmacologically or genetically inhibited suggest that Shh may 
directly and/or indirectly act as a regulator of the gastrin-gastric acid negative feedback 
mechanism regulating acid secretion (El-Zaatari et al., 2008; El-Zaatari et al., 2007; El-Zaatari 
et al., 2010; Xiao et al., 2010). Treatment of mice with cyclopamine, an inhibitor of Hedgehog 
signaling receptor Smo, results in elevated circulating gastrin levels (El-Zaatari et al., 2008). 
Loss of Shh may impair acid secretion by decreasing the activity or expression of parietal 
cell H+-K+-ATPase. The reduction in acid secretion would reduce somatostatin release from 
D-cells of the stomach thus removing the somatostatin-inhibitory effect on gastrin secretion. 
In support of this hypothesis, we observed that the lack of acid secretion in the 
HKCre/ShhKO mice was accompanied by significant hypergastrinemia. Treatment of 
HKCre/ShhKO mice, with the somatostatin analogue octreotide, significantly suppressed 
hypergastrinemia and subsequently restored differentiation of the zymogen cell lineage and 
parietal cell function (Xiao et al., 2010). Given that gastrin promotes the growth of gastric 
adenocarcinomas, the role of Shh as a regulator of gastrin and somatostatin secretion has 
important implications for the study of gastric cancer. 
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2.3 Decreased Shh expression during Helicobacter pylori infection 
Helicobacter pylori (H. pylori) colonizes the stomachs of half the world’s population (Bergman 
et al., 2005). Chronic inflammation caused by persistent H. pylori infection is the most 
consistent lesion that causes the development of gastric cancer (Correa et al., 1975; Correa P, 
2007). The gastric mucosal changes of H. pylori infection begin with chronic inflammation 
followed by hyperproliferation, parietal cell atrophy, and metaplastic cell lineage changes 
including spasmolytic polypeptide-expressing metaplasia (SPEM), intestinal metaplasia and 
antralization of glands that then proceeds with dysplasia and eventually cancer (Correa P, 
2007) (Goldenring JR, 2006). Loss of mature parietal cells from the gastric glands of the 
stomach plays a central role in the progression of these gastric alterations. Atrophy leads to 
alterations in the cell lineages with the expansion of metaplastic mucous cells. Since stomach 
secretes numerous factors such as TGFβ, Wnt, FGFs and including Hedgehog proteins that 
are responsible for the differentiation of the gastric epithelium, one favored explanation 
linking inflammation and progression to cancer is due to the loss of Hedgehog as result 
parietal cell atrophy (reviewed in (Katoh & Katoh, 2006)). In conditions such as gastric 
atrophy and intestinal metaplasia, where normal gastric morphogenesis is lost, Shh is 
reduced or absent (Dimmler et al., 2003; Shiotani et al., 2005a; Shiotani et al., 2005b; Suzuki 
et al., 2005; van den Brink et al., 2002; Van Den Brink et al., 2001). In support of this, in 
Mongolian gerbils infected with H. pylori loss of Shh expression correlates with loss of 
parietal cells, impaired maturation of the zymogenic chief cells in gastric glands, and 
intestinal metaplasia (Suzuki et al., 2005). Therefore, loss of Shh signaling may address the 
impairment of chief cell differentiation and the development of intestinal metaplasia found 
in late stage H. pylori associated gastritis. 
It is only until recently that the mechanism responsible for the loss of Shh expression during 
H. pylori infection has been elucidated in vivo (Minegishi Y, 2007; Waghray et al., 2010). As 
reviewed, acid secretion plays an important role in maintaining Shh expression and 
secretion in the adult stomach (Minegishi Y, 2007; Waghray et al., 2010; Zavros, 2007; Zavros 
et al., 2008). Experiments using models of parietal cell dysfunction such as the histamine 
H(2) receptor-knockout mice in vivo (Minegishi Y, 2007) and isolated rabbit gastric glands 
and canine parietal cells treated with H+,K+-ATPase blocker omeprazole (Zavros, 2007; 
Zavros et al., 2008), demonstrate that in the absence of acid secretion Shh expression is 
significantly reduced. Thus hypoacidity would induce the loss of Shh typically found in H. 
pylori infection. However, another group of potential candidates that may inhibit Shh 
expression are the inflammatory cytokines released in response to H. pylori colonization. For 
example, exogenous infusion of interferon-γ (IFN-γ) alone is sufficient to induce 
hypergastrinemia and metaplasia in mice, but very little is known about the regulation of 
Shh by pro-inflammatory cytokines (Zavros et al., 2003). Alternatively, IL-1β correlates with 
gastric atrophy and gastric cancer (El-Omar et al., 2000; El-Omar et al., 2001) and is a potent 
inhibitor of gastric acid secretion (El-Omar et al., 2003) making this cytokine also a strong 
candidate for the causal role of Shh expression. A recent study using Shh-LacZ reporter mice 
demonstrates that IL-1β produced during Helicobacter infection inhibited gastric acid and 
subsequently Shh expression through IL-1 receptor activation (Waghray et al., 2010). The 
investigators concluded from this study that proinflammatory cytokine IL-1β reduces Shh 
expression and function in the gastric mucosa by reducing acid secretion from parietal cells 
(Waghray et al., 2010). Since Shh induces H+,K+-ATPase gene expression in isolated canine 
parietal cells (Stepan et al., 2005), the investigators rationalized that chronically suppressed 
www.intechopen.com
 Cancer Stem Cells - The Cutting Edge 
 
320 
levels of Shh may eventually reduce enzyme expression that is sufficient to induce gastric 
atrophy and thus, inhibit Shh expression in parietal cells (Waghray et al., 2010). Our study 
using the HKCre/ShhKO mouse model demonstrates that in the absence of inflammation, 
although Shh induces foveolar hyperplasia and hypochlorhydria, this was not sufficient to 
induce atrophy (Xiao et al., 2010). Therefore, there may be a requirement for additional 
factors, such as inflammatory cytokines, for parietal cell atrophy to develop. 
3. Over-expression of sonic hedgehog signaling in gastrointestinal cancers: 
The role of Shh within the tumor microenvironment 
3.1 Over-expression of sonic hedgehog in cancer 
The over-expression of Shh signaling components in correlation with the development of 
gastrointestinal cancers was first recognized through investigation of mRNA expression of 
Shh and Ihh in tumors throughout the gastrointestinal tract (Berman et al., 2003). Ptch and 
Gli mRNA transcript levels were measured as indicators of Hedgehog pathway activity, 
whereby increased Ptch expression was coincident with elevated Shh. In vivo data suggested 
that the effect of increased Shh was to promote aberrant cell proliferation as tumor growth 
regressed with treatment of tumor-bearing mice with the Hedgehog pathway inhibitor 
cyclopamine. These data also confirmed that the tumor growth was indeed stimulated by 
the Hedgehog autonomous signaling network rather than a result of mutation. Further 
characterization of Ptch1 and Gli1 expression within the gastric tumor microenvironment 
was performed using a collection of human biopsies representing matched normal tissue as 
compared to inflamed tissue, tubular adenocarcinoma, papillary adenocarcinoma and 
signet-ring cell carcinomas from a series of patients (Ma et al., 2005). In these human 
samples, elevated Shh corresponded to increased Ptch1 and Gli1 only in cancerous tissue 
and not in the surrounding normal tissue. Elevated Hedgehog pathway activation was most 
common in poorly differentiated and high-grade samples, implicating Shh as an inducer of 
an aggressive phenotype able to evade normal cell cycle control (Ma et al., 2005). 
Further work with both intestinal and diffuse gastric cancer-derived cell lines and 
corresponding human samples, compared to intestinal metaplasias, were used to localize 
Shh signaling by cell type in the setting of tumor formation and included an examination of 
the role of Ihh and Dhh (Fukaya et al., 2006). In samples collected from patients with 
intestinal metaplasia, the mRNA level of Hedgehog signaling pathway components were 
weakly expressed, while in contrast both Ihh and Shh were increased. Interestingly, the 
intestinal phenotype expressed low mRNA levels of the downstream targets Smo, Gli1 and 
Gli2 while the diffuse-type phenotype highly expressed Ptch, Smo, Gli1 and Gli2. The 
complementary immunohistochemical evaluation of the cells expressing these proteins was 
crucial, revealing that very little expression of any of the Hedgehog signaling components 
were detectable in any cell type in intestinal type cancers. However, the diffuse-type 
samples showed strong Ihh staining throughout the epithelial cancer cells while Shh was 
expressed in fibroblastic cells co-staining with the markers vimentin, α-actin and desmin 
(Fukaya et al., 2006). Gastric cancer cell lines used in proliferation assays with cyclopamine 
treatment confirmed these results implicating Hedgehog activation in increased cell 
proliferation in cancers representative of the diffuse-type development with high expression 
of Smo. In contrast to patients with atrophic gastritis that show loss of Shh protein 
expression, over-expression of Shh appears in gastric carcinoma. The mechanism by which 
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Hedgehog is first elevated in cancer and then able to act on cancer cells to induce their 
proliferation remains largely unknown. 
3.2 Hedgehog signaling regulates cell-cycle progression in gastric cancer cells 
There is overwhelming evidence showing that elevated Hedgehog is capable of promoting 
cancer cell proliferation and evasion of apoptosis, and recent work has begun to unravel the 
mechanistic details behind this finding. The treatment of the gastric cancer cell line, SNU16, 
with cyclopamine consistently induces cell apoptosis and arrest of cells in the G0/G1 phase 
of the cell cycle (Han et al., 2009). Cytochrome c staining within the mitochondria of 
cyclopamine-treated cells was characteristic of cells entering the apoptotic pathway, with 
diffuse staining throughout the cell, while in control cells cytochrome c staining co-localized 
with a marker for mitochondria only. The Bcl-2 protein is one of the key proteins regulating 
the release of cytochrome c from mitochondria, and the cyclopamine-treated cells exhibited 
significant decreases in both Bcl-2 and Gli1 by immunoblot. Collectively, these data suggest 
that the Shh signaling pathway is important in maintaining the level of anti-apoptotic 
proteins within cancer cells (Han et al., 2009). This study was limited by the use of only one 
type of gastric cancer cell line, however, a recent study performed a similar analysis on the 
SNU-16 cell line as well as the AGS, KATO-III, SNU-5, SNU-601 and SNU-638 cell lines (Lee 
et al., 2010). Cells either over-expressing Shh or having Shh knocked-down were co-cultured 
with H. pylori as the factor initiating cell apoptosis. Serial passage of one of the AGS/N-Shh 
over-expressing clones exposed to H. pylori showed adopted resistance to H. pylori-
associated apoptosis concomitant with elevations in all Hedgehog signaling components, 
therefore cell-cycle protein activation was further characterized in this cell line. An 
immunoblot showed an absence of Bcl-2, confirming the results of Han, et al. (Han et al., 
2009), as well as an increase in Cyclin D1 (Lee et al., 2010). These studies demonstrate that 
the reactivation of the Shh signaling pathway in response to infectious or inflammatory 
stimuli is critical to the inhibition of programmed cell death. It also provides an interesting 
hypothesis that mutated gastric cells evade apoptosis and with a proliferative stimulus may 
repopulate the epithelium and lead to tumor development. 
Another interesting update to the role of Hedgehog signaling in the regulation of the cell-
cycle comes from a biochemical analysis that demonstrates a direct physical interaction 
between Ptch and the cyclins (Barnes et al., 2001). Cyclin B1 is a critical regulator of mitotic 
cell division. During G2 phase, cyclin B1 accumulates in the nucleus as a part of cyclin 
dependent kinase 1 (CDK1) protein complex and plays a critical role during the G2/M 
phase transition of the cell cycle (Jenkins, 2009). Interestingly, Shh and Ptch participate in 
the G2/M phase checkpoint in a ‘non-canonical’ pathway that may be independent of Smo 
and Gli (Barnes et al., 2001). In the absence of Hedgehog ligand Ptch1 binds to cyclin B1 and 
inhibits the translocation to the nucleus. In the presence of Shh ligand, Ptch1 dissociates 
from cyclin B1 and cyclin B1 is translocated to the nucleus and promotes cell cycle 
progression.). Given that Ptch functions as a ‘tumor suppressor’, it is almost intuitive to 
hypothesize that within the tumor microenvironment, where Shh is elevated, increased 
proliferation is expected. In support of this hypothesis, mutations in Ptch have been linked 
to both cancers such as basal cell carcinomas and medulloblastomas (Ruiz i Altaba et al., 
2002). Although these examples provide a firm genetic link between mutations of the 
Hedgehog signaling pathway and the incidence of cancer, there is little biological evidence 
of the underlying mechanisms linking Hedgehog signaling, cell-cycle progression and its 
relevance to gastric cancer progression. 
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4. The role of Bone-marrow derived mesenchymal stem cells (BM-MSCs) in 
promoting gastric cancer progression 
4.1 Bone marrow-derived mesenchymal stem cell (BM-MSCs) recruitment to areas of 
chronic inflammation 
Migration and differentiation of stem or progenitor cells within the stem cell niche of tissues 
are appropriately regulated to maintain normal organ structure and function. Although 
stem cells are critical to gastrointestinal development, tissue repair and normal function, the 
malignant transformation of these cells is critical for initiation of cancer including stomach, 
colon, liver and pancreas (reviewed in (Merchant & Matsui, 2010)). Traditionally, cancer has 
been viewed as a disease in which environmental factors induced mutations in critical 
oncogenes and tumor suppressor genes within a normal cell leading to cancer development. 
Recently, interest in cancer stem cells has arisen, and evidence has emerged demonstrating 
that cancer originates from the transformation of tissue stem cells induced by regulatory 
signals generated within the tumor microenvironment. Such regulatory signals contribute to 
the cancer stem cell niche by promoting growth of developing tumors through stimulating 
angiogenesis and the evasion of normal cell death. The intrinsic malignant transformation of 
stem cells occurs at an accelerated rate under certain environmental pressures that include 
injury and inflammatory cytokines. 
Recruitment of bone marrow-derived mesenchymal stem cells (BM-MSCs) to the local tissue 
environment is a phenomenon that is traditionally related to the development of an 
inflammatory response during tumor development in a variety of organs throughout the 
body (Anjos-Afonso F, 2004; Coffelt et al., 2009; Kidd et al., 2009; Santamaria-Martínez et al., 
2009; Shinagawa et al., 2010). The mechanism by which BM-MSCs alter the tissues to which 
they are recruited is unknown. With chronic inflammation of the stomach bone marrow-
derived cells are recruited to the epithelium where, as the inflammatory response 
progresses, these cells repopulate entire glands and with tumor formation comprise part of 
the stroma (Houghton J, 2004). Further investigation then demonstrated that mesenchymal 
stem cells (MSCs) co-expressed gastric markers suggesting they could become incorporated 
within the gastric epithelium upon recruitment and contribute to the tumor stroma 
(Houghton J, 2004). Recently, this has been confirmed through an examination of MSC-like 
cells isolated from human gastric cancer samples which were shown to share many of the 
same properties as bone marrow-derived MSCs (Cao et al., 2009). To expand on these 
findings, a further analysis was performed that compared the MSC-like cells isolated from 
cancer to the same cells from non-cancerous tissue within the same patient, revealing that 
both populations express similar cells surface markers and genes characteristics of 
pluriopotent stem cells, mesenchymal cells and factors related to angiogenesis (Xu et al., 
2011). Cell cycle analysis also revealed that there was significantly more cancer derived 
MSC-like cells within the S phase of the cell cycle as compared to the non-cancerous MSC-
like cells isolated and normal BM-MSCs (Xu et al., 2011) suggesting that these cells are 
actively proliferating within the inflamed environment. 
To understand how MSCs become carcinogenic, isolated normal BM-MSCs were serially 
passaged in vitro for over a year and monitored at several stages for malignant 
transformation by assaying colony formation, growth in soft agar and tumor development 
in xenografts established in immunocompetent mice (Li et al., 2007). After 12 months of 
continuous culture, carcinogenic potential was exhibited based on the results of each of 
these assays and the MSCs were termed “spontaneously transformed”, or stMSCs (Li H, 
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2007). We have extended these findings by demonstrating that proliferation of stMSCs is 
dependent on Hedgehog signaling (Figure 2). To examine the role of Hedgehog signaling in 
stMSC growth in vivo, subcutaneous xenografts using MSCs were established in C57Bl/6 
mice. Mice injected with culture media alone were used as controls. Tumors approximately 
100-200 mm3 were measured in mice within 7 days of injection. Media controls showed no 
tumor growth. After the tumors had grown to approximately 100-200 mm3, mice bearing 
these tumors were injected daily with the hedgehog signaling inhibitor cyclopamine 
(MSCsCyclopamine) or vehicle (MSCsVehicle). While the tumors in the vehicle treated mice 
(MSCsVehicle) continued to grow over the next 6 days (Figure 2A), the cyclopamine treated 
animals (MSCsCyclopamine) ceased to grow and began to regress in size (Figure 2A). 
Interestingly, mice injected with stMSCs expressing knockdown of Shh (MSCShhKO) cells 
showed delayed tumor growth and in some animals no tumors at all (Figure 2A). These data 
show that the Hedgehog signaling pathway is a key component for the growth and 
proliferation of stMSCs in vivo. 
 
 
Fig. 2. Hedgehog pathway activity and requirement for growth of stMSCs in vivo. (A) 
Change in tumor volume (mm3) in response to either vehicle or cyclopamine treatment, or 
transduced MSCShhKO59 cells over the 12 day experiment. P<0.05 compared to MSCVehicle, n = 
3-6 mice per group, data shown as mean ± SEM. Arrow shows start of cyclopamine 
treatment. (B) Changes in tumor sizes dissected from vehicle-treated and cyclopamine-
treated stMSCWT injected mice 12 days after xenograft 
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Fig. 3. Changes in Shh secretion and gene expression from IFNγ-treated stMSCs. (A) Western 
blot analysis of changes in secreted Shh protein (19-kDa, ShhNp) in media collected from 
stMSCs treated with vehicle, cyclopamine (Cyc.), IFNγ or Cyc. Plus IFNγ. (B) RNA was 
extracted from stMSCs treated with vehicle, cyclopamine (Cyc.), IFNγ or Cyc. Plus IFNγ  and 
Smo, Ptch and Gli gene expression analyzed by quantitative real-time PCR. *P<0.05 
compared to vehicle treated cells, n = 4 individual experiments 
The gene expression profile of these cells was compared to early passage BM-MSCs and 
MSCs isolated from naturally occurring tumors in both aged mice and humans. Carcinogenic 
MSCs of each type showed uniform increases in expression of factors important in 
pluripotency and matrix remodeling and metastasis while harboring clinically relevant p53 
mutations in addition to alterations in other tumor suppressor genes (Li et al., 2007). These 
results have since been confirmed in a study of in vivo transformation of MSCs, using BM-
MSCs isolated from 2, 8 and 26 month old C57Bl/6 mice in which each set of cell populations 
were grown in vitro to homogeneity then gene expression compared using the Affymetrix 
Mouse Genome 430 2.0 GeneChip Array. Of particular interest, between the 8 and 26 month 
old groups, MSCs displayed significant decreases (> 2 fold) in p53, Cdkn1a, CHEK2 and p21 
gene expression, among other apopotic pathway genes (Wilson et al., 2010). Immunoblot in 
26 month old MSCs indicated p53 protein expression was essentially absent (Wilson et al., 
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2010). While spontaneous transformation of human MSCs (hMSCs) has been more 
controversial, it has been shown in similar studies that they do undergo transformation in 
vitro. In fact, data indicate that hMSCs adopt carcinogenic properties as early as 25 days 
after their initial isolation (Røsland et al., 2009). While these data suggest that the natural 
process of aging results in mutation and evasion of normal cell death in BM-MSCs, it may 
not answer the question of what these cells are doing once recruited to a site of inflammation 
and whether inflammatory insults can also result in modulation of MSC phenotype or 
transformation. 
4.2 Bone marrow-derived mesenchymal stem cells (BM-MSCs) express sonic 
hedgehog 
While there is no doubt that increased Hedgehog is apparent in cancer and plays a critical 
role in driving cancer progression, the source of its increased expression has yet to be 
identified. One hypothesis is that remodeling at the DNA level is responsible for increased 
Shh expression in gastric cancer cells. In studies looking at human gastric cancer samples 
representative of each clinical stage of gastric cancer progression, elevated Shh was correlated 
with both loss of methylation within the Shh promoter region and hypermethylation of the 
promoter for Hedgehog interacting protein, an antagonist of the Hedgehog signaling pathway, 
changes which synergize to produce more Shh gene transcription (Taniguchi et al., 2007). 
During gastric cancer development it is shown that both Ihh and Shh are increasing within 
the cancer promoting cells of the epithelium and within a population of cells recruited to the 
mesenchyme of the stomach, respectively. An alternative hypothesis may be that in cases in 
which organs of the gastrointestinal tract are acutely injured or have developed carcinoma, 
there may be an intimate relationship between the inflammatory response and stimulation 
of Hedgehog secretion. 
There is evidence in medulloblastomas of the cerebellum that expression of the cytokine 
interferon-gamma (IFNγ) during the immune response leads to a direct elevation of Shh 
protein (Lin et al., 2004; Sun L, 2010; Wang J, 2004; Wang J, 2003). Our laboratory has 
investigated this relationship within stMSCs harboring p53 mutations that are aggressively 
carcinogenic (Houghton et al., 2010; Li H, 2007). Bone marrow-derived mesenchymal stem 
cells (BM-MSCs) were first recognized as regulators of gastric carcinogenesis with the 
observation that they are recruited to the site of tumor formation in mice infected with 
Helicobacter felis (H. felis) and comprise part of the stroma of developing tumors (Houghton J, 
2004). We have observed that treatment of these cells in vitro with recombinant IFN induces 
a two-fold increase in Shh secretion (Figure 3A) and gene expression of Hedgehog signaling 
components Smo, Ptch and Gli (Figure 3B). An interesting observation that was made from 
these data is that cyclopamine pre-treatment of IFNγ-treated cells resulted in an inhibition of 
Shh secretion compared to the IFNγ treatment alone (Figure 3A). These data would suggest 
that there is an autocrine feedback mechanism regulating Shh production from the stMSCs 
in response to IFNγ. Collectively, these data provide compelling evidence that the recruited 
stMSCs are in fact the source of local Shh, and may be a first step in identifying the 
historically elusive source of Shh in advanced gastrointestinal tumors. 
4.3 Bone marrow-derived mesenchymal stem cells (BM-MSCs) as regulators of cancer 
stem cells 
Recent work with stMSCs using a mouse model of breast cancer has defined the importance 
of aberrant immune responses in the in vivo transformation and maintenance of these cells 
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(Houghton et al., 2010). The local tissue environment may be considered carcinogenic, 
whereby with the ablation of tumor necrosis factor α (TNFα), the progression of neoplasia 
stimulated by recruited MSCs within epithelia can be halted (Houghton et al., 2010). A study 
using human MSCs transduced to express TNF-related apoptosis-inducing ligand (TRAIL), 
are recruited to the site of tumor formation where they produce significant cancer cell 
apoptosis in a model of squamous and lung cancer cells, enhancing the effects of 
chemotherapeutic agents (Loebinger et al., 2010). Based on the stromal cell phenotype, 
investigators suggest that recruited MSCs take on the phenotype of cancer-associated 
fibroblasts (CAF) (Quante et al., 2011). In IL-1β and H. felis-infected mouse models, MSCs 
are recruited to the gastric epithelium and adopt expression of α−smooth muscle actin, 
vimentin and FSP1 similar to CAFs (Quante et al., 2011). Differentiated CAFs also express 
high levels of the chemokines and cytokines such as IL-6, TGF-β, TNFα, and SDF-1α, as 
compared to wild-type gastric myofibroblasts (Quante et al., 2011). This work suggests 
several possible roles for these cells in cancer progression, in that they may be involved in 
regulating the local environment to form a niche for cancer stem cells, impacting the 
inflammatory response through release of soluble factors and cell-cell interaction or 
behaving as cancer stem cells themselves. 
CD44 is an adhesion molecule expressed in cancer stem cells (Takaishi et al., 2009). The 
characterization of the resident stem cells of the gastric epithelium is a constantly evolving 
field of study within gastrointestinal research. While the identification of the CD44 positive 
cells is unknown, the activation and proliferation within a chronic inflammatory response 
has indicated that these cells may be the source of the cancer stem cell in the stomach 
(Ishimoto et al., 2011; Takaishi et al., 2009). The CD44 positive cell population isolated from 
several human gastric cancer cell lines by flow cytometry displays the phenotype of a cancer 
stem cell when assayed for spheroid colony formation and in vivo tumorigenicity (Takaishi 
et al., 2009). Higher CD44 expression was correlated with more aggressive tumor formation 
when cell lines were transplanted into the skin and stomach of immunodeficient mice, an 
effect that could be ablated by lentiviral knockdown using shRNA against the CD44 gene 
(Takaishi et al., 2009). Studies of specific CD44 variants produced by alternative splicing 
indicate that H. pylori infection and inflammation result in upregulation of CD44v6 and 
CD44v9, while CD44v6 is expressed in the normal gastric mucosa (Fan et al., 1996). Given 
the recently reported role of Shh as one of the primary stimuli in the induction of cancer 
stem cell proliferation (Song et al., 2011), we sought to identify the role of Hedgehog as a 
mediator of stMSC-induced proliferation of CD44 positive cancer stem cells. Figure 4 shows 
stomach sections collected from mice that were transplanted with stMSCVect cells tagged 
with red fluorescent protein (RFP) and injected with either phosphate buffered saline 
(control, PBS) or IFNγ for 21 days. Stomach sections were collected and immunostained for 
proliferation marker bromodeoxyuridine (BrdU) and RFP. RFP-tagged stMSCVect cells were 
recruited to the gastric mucosa of mice injected with IFNγ(Figure 4B, E) compared to the 
absence of RFP-tagged MSCVect cells in the stomachs of PBS-injected mice (Figure 4A). 
Although IFNγ-treatment appeared to increase the number of proliferating cells within the 
gastric mucosa (Figure 4B) compared to the PBS-injected mice (Figure 4A), RFP-tagged 
MSCvect cells stained negative for BrdU (Figure 4B, E). Interestingly, when the same section 
were immunostained for BrdU and cancer stem cell marker CD44, it appeared as though the 
proliferating cells were in fact CD44 positive. These results may suggest that BM-MSCs, 
harboring mutations, are recruited to the sites of inflammation and drive cancer progression 
through the elevated production of Shh protein that may subsequently induce proliferation 
of the cancer stem cells. 
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Fig. 4. Proliferation cells within the gastric mucosa of IFNγ-treated mice. Gastric mucosa 
collected from mice transplanted with stMSCvect cells injected with (A) PBS or (B, E) IFNγ 
were BrdU labeled (blue) and co-stained with anti-RFP antibody (brown). Higher 
magnification of image in (B) is shown in (E) where arrows show separate BrdU positive 
proliferating cells and RFP-tagged stMSCs. Gastric mucosa collected from mice transplanted 
with stMSCvect cells injected with (C) PBS or (D, F) IFNγ were BrdU labeled (blue) and co-
stained with anti-CD44 antibody (brown). Higher magnification of image in (D) is shown in 
(F) where arrows show BrdU positive proliferating cells co-expressing gastric cancer cell 
maker CD44. Arrows shown in (D) indicate the expression of CD44 positive cells that are 
not proliferating. Representative of n = 4-6 mice per group 
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5. Conclusion: The hedgehog signaling network and the cancer stem cell 
compartment 
While loss of Shh is associated with gastric atrophy, the reemergence and over-expression of 
Shh protein in gastric cancer is an observation that is well established (Berman et al., 2003). 
The underlying mechanism(s) regulating Shh re-expression and over-expression in malignant 
 
 
Fig. 5. Proposed model for the role of Shh in the development of gastric cancer. Th1 
proinflammatory cytokine IFNg induces Shh expression and secretion from BM-MSCs 
within the bone marrow compartment. Shh regulates the expression of the CXCR4 that is 
critical for the recruitment of BM-MSCs to the stomach in response to SDF-1a. The 
recruitment of BM-MSCs expressing and actively secreting Shh in an environment rich in 
IFNγ repopulate the damaged gastric epithelium. Shh then induces proliferation of gastric 
cancer stem cells 
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that the molecular events begin in the bone marrow compartment in response to inflammation 
whereby in the stomach is induced by H. pylori infection. Several groups have implicated the 
CXCR4/SDF-1 axis in the recruitment of mesenchymal stem cells to sites of injury as well as 
to areas of developing carcinoma/tumor stroma (Haider et al., 2008; Kyriakou et al., 2008). 
What emerges from this body of work is a plausible mechanism for the recruitment of MSCs 
to the site of developing carcinoma. SDF-1α, that is secreted from the infected epithelium 
then signals to the BM-MSCs to initiate recruitment to the stomach. The recruitment of BM-
MSCs expressing and actively secreting Shh in an environment rich in inflammatory cytokines 
including IFNγ repopulate the damaged gastric epithelium. Shh then acts on the gastric 
cancer stem cells to induce proliferation and eventually tumor development (Figure 5). BM-
MSCs play a multifaceted role contributing to the cancer stem cell niche but also promote 
growth of developing tumors through stimulating angiogenesis and the evasion of normal 
cell death within the cancer stem cell population. Therefore, it is critical to define the 
mechanisms by which BM-MSCs support these alterations in the setting of cancer 
development in order to create new therapeutic approaches. The intrinsic transformation 
into malignant cells, which can occur at an accelerated rate under certain environmental 
pressures, only highlights the need for more advanced studies. 
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